|
🐜
|
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study
24 auth.
J. Haschka,
M. Englbrecht,
A. Hueber,
B. Manger,
A. Kleyer,
M. Reiser,
S. Finzel,
H. Tony,
S. Kleinert,
M. Feuchtenberger,
...
M. Fleck,
K. Manger,
W. Ochs,
M. Schmitt-Haendle,
J. Wendler,
F. Schuch,
M. Ronneberger,
H. Lorenz,
H. Nuesslein,
R. Alten,
W. Demary,
J. Henes,
G. Schett,
J. Rech
|
7 |
2015 |
7
🐜
|
|
🐜
|
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
26 auth.
J. Rech,
A. Hueber,
S. Finzel,
M. Englbrecht,
J. Haschka,
B. Manger,
A. Kleyer,
M. Reiser,
J. Cobra,
C. Figueiredo,
H. Tony,
S. Kleinert,
J. Wendler,
F. Schuch,
M. Ronneberger,
...
M. Feuchtenberger,
M. Fleck,
K. Manger,
W. Ochs,
M. Schmitt-Haendle,
H. Lorenz,
H. Nuesslein,
R. Alten,
J. Henes,
K. Krueger,
G. Schett
|
6 |
2015 |
6
🐜
|
|
🐜
|
Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions
11 auth.
S. Kleinert,
H. Tony,
K. Krueger,
J. Detert,
F. Mielke,
K. Rockwitz,
...
R. Schwenke,
Gerd-Rüdiger Burmester,
R. Diel,
M. Feuchtenberger,
C. Kneitz
|
6 |
2012 |
6
🐜
|
|
🐜
|
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
57 auth.
G. Burmester,
F. Buttgereit,
C. Bernasconi,
J. Álvaro-Gracia,
Nidia Castro,
M. Dougados,
C. Gabay,
J. Laar,
J. Nebesky,
A. Pethoe-Schramm,
C. Salvarani,
M. Donath,
M. John,
A. Constantin,
J. Gottenberg,
...
S. Loiseau-Peres,
M. Nguyen,
T. Schaeverbeke,
R. Alten,
C. Amberger,
W. Biewer,
K. Boche,
G. Burmester,
A. Engel,
M. Feuchtenberger,
M. Fleck,
G. Gauler,
B. Heilig,
Maria Höhle,
C. Iking-Konert,
P. Kästner,
D. Kofler,
K. Krueger,
C. Kühne,
R. Kurthen,
H. Schulze-Koops,
H. Schwenke,
M. Sieburg,
C. Specker,
H. Tony,
S. Wassenberg,
J. Wendler,
R. Caporali,
O. Epis,
M. Matucci-Cerinic,
A. Dubikov,
R. Kamalova,
M. Korolev,
V. Mazurov,
E. Puntus,
N. Damjanov,
T. Ilić,
M. Lazarevic,
S. Milenkovic,
M. Petronijevic,
E. Bouajina,
M. Elleuch
|
6 |
2020 |
6
🐜
|
|
🐜
|
Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development
13 auth.
P. Ströbel,
M. Marino,
M. Feuchtenberger,
Anne-Sophie Rouzière,
H. Tony,
U. Wulbrand,
R. Förster,
A. Zettl,
Nancy Lee Harris,
H. Kreipe,
...
R. H. Laeng,
H. Müller-hermelink,
A. Marx
|
5 |
2005 |
5
🐜
|
|
🐜
|
Comparison of two interferon-γ release assays and tuberculin skin test for detecting latent tuberculosis in patients with immune-mediated inflammatory diseases
10 auth.
S. Kleinert,
O. Kurzai,
J. Elias,
K. Marten,
C. Engelke,
M. Feuchtenberger,
...
J. Sandstede,
M. Frosch,
H. Tony,
C. Kneitz
|
5 |
2010 |
5
🐜
|
|
🐜
|
Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study
10 auth.
S. Kleinert,
H. Tony,
A. Krause,
M. Feuchtenberger,
S. Wassenberg,
C. Richter,
...
E. Röther,
W. Spieler,
H. Gnann,
B. Wittig
|
5 |
2011 |
5
🐜
|
|
🦁
|
Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study
9 auth.
M. Feuchtenberger,
S. Kleinert,
S. Schwab,
P. Roll,
E. Scharbatke,
Eva Ostermeier,
...
R. Voll,
A. Schäfer,
H. Tony
|
5 |
2012 |
5
🦁
|
|
🐜
|
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs
27 auth.
C. Figueiredo,
H. Bang,
J. Cobra,
M. Englbrecht,
A. Hueber,
J. Haschka,
B. Manger,
A. Kleyer,
M. Reiser,
S. Finzel,
H. Tony,
S. Kleinert,
J. Wendler,
F. Schuch,
M. Ronneberger,
...
M. Feuchtenberger,
M. Fleck,
K. Manger,
W. Ochs,
M. Schmitt-Haendle,
H. Lorenz,
H. Nuesslein,
R. Alten,
J. Henes,
K. Krueger,
J. Rech,
G. Schett
|
5 |
2016 |
5
🐜
|
